Literature DB >> 7037642

Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins.

R S Munford, C L Hall, J M Dietschy.   

Abstract

These studies were undertaken to investigate the binding of gram-negative bacterial lipopolysaccharides (LPS) to high-density lipoproteins (HDL) of rat plasma. Purified Salmonella typhimurium LPS, intrinsically labeled with [3H]-galactose, bound rapidly in vitro to isolated rat HDL. Maximal binding of LPS to HDL occurred when LPS and HDL were incubated with lipoprotein-free plasma (rho greater than 1.21 g/ml). Since LPS, when purified, form large aggregates, we tested the hypothesis that disaggregation of LPS enhances LPS-HDL binding. We found that calcium chloride (1 mM), an agent which prevents LPS disaggregation, inhibited binding of LPS to HDL by interfering with the modification of LPS by lipoprotein-free plasma. Conversely, sodium deoxycholate (0.15 g/dl), which disaggregates LPS, greatly increased binding of LPS to HDL in the absence of lipoprotein-free plasma. Analysis of labeled LPS by sodium deodecyl sulfate-polyacrylamide gel electrophoresis showed only minor differences in the sizes of LPS molecules before and after binding to HDL, suggesting that chemical modification of LPS is not required for binding. The results provide evidence that disaggregation increases the binding of LPS to HDL.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7037642      PMCID: PMC350945          DOI: 10.1128/iai.34.3.835-843.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Biosynthesis of bacterial lipopolysaccharide. I. Enzymatic incorporation of galactose in a mutant strain of Salmonella.

Authors:  M J OSBORN; S M ROSEN; L ROTHFIELD; B L HORECKER
Journal:  Proc Natl Acad Sci U S A       Date:  1962-10-15       Impact factor: 11.205

2.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

3.  Electrophoretic separation of plasma lipoproteins in agarose gel.

Authors:  R P Noble
Journal:  J Lipid Res       Date:  1968-11       Impact factor: 5.922

4.  Physicochemical studies on a lipopolysaccharide from the cell wall of Azotobacter vinelandii.

Authors:  A L Olins; R C Warner
Journal:  J Biol Chem       Date:  1967-11-10       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  The dispersion of gram-negative lipopolysaccharide by deoxycholate. Subunit molecular weight.

Authors:  J W Shands; P W Chun
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

7.  The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits.

Authors:  J C Mathison; R J Ulevitch
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

8.  Size heterogeneity of Salmonella typhimurium lipopolysaccharides in outer membranes and culture supernatant membrane fragments.

Authors:  R S Munford; C L Hall; P D Rick
Journal:  J Bacteriol       Date:  1980-11       Impact factor: 3.490

9.  Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats.

Authors:  M A Freudenberg; T C Bøg-Hansen; U Back; C Galanos
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma.

Authors:  R C SKARNES; F S ROSEN; M J SHEAR; M LANDY
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307

View more
  30 in total

1.  Distribution and kinetics of lipoprotein-bound endotoxin.

Authors:  J H Levels; P R Abraham; A van den Ende; S J van Deventer
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.

Authors:  M M Wurfel; E Hailman; S D Wright
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

3.  Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes.

Authors:  Baomei Shao; Robert S Munford; Richard Kitchens; Alan W Varley
Journal:  Innate Immun       Date:  2012-03-22       Impact factor: 2.680

4.  Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor.

Authors:  H S Warren; M L Glennon; N Wainwright; S F Amato; K M Black; S J Kirsch; G R Riveau; R I Whyte; W M Zapol; T J Novitsky
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

5.  Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide.

Authors:  J M Cavaillon; C Fitting; N Haeffner-Cavaillon; S J Kirsch; H S Warren
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

6.  Turbidimetric method for quantifying serum inhibition of Limulus amoebocyte lysate.

Authors:  T J Novitsky; P F Roslansky; G R Siber; H S Warren
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

Review 7.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties.

Authors:  A Shnyra; K Hultenby; A A Lindberg
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I.

Authors:  W A Flegel; M W Baumstark; C Weinstock; A Berg; H Northoff
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

10.  LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.

Authors:  A C Vreugdenhil; A M Snoek; C van 't Veer; J W Greve; W A Buurman
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.